Inventiva IVA
NASDAQ IVA
$3.89 -0.06 (-1.39%)
As of: Nov 11, 2026 · 12:14 PM EST

Inventiva (IVA) Non-Current Deferred Revenue (2018 - 2025)

Updated

Inventiva (IVA) posted Non-Current Deffered Revenue of $146,669 for Q4 2025, up 28.3% from $114,340 a year earlier.

Analysis

Inventiva (IVA) Non-Current Deferred Revenue (2018 - 2025) Analysis & Trends

Since Q4 2018, Inventiva has reported Non-Current Deffered Revenue for 7 quarters.

  • Annual Non-Current Deffered Revenue has increased for three consecutive years, with a three-year compound annual growth rate of 37.7% (FY2022 to FY2025).
  • In prior years, Inventiva's Non-Current Deffered Revenue was $114,340 in FY2024 (+51.8%), $75,316 in FY2023 (+34.2%) and $56,114 in FY2022.
  • The Q4 2025 figure stands as the highest quarterly Non-Current Deffered Revenue since Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Inventiva 763.29 Mn 38.98 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 148,015.88
Jun 30, 2025 147,765.91
Dec 31, 2024 111,345.83
Dec 31, 2023 77,477.34
Dec 31, 2022 58,634.14
Dec 31, 2018 1.91 Mn
API Access

Inventiva Non-Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=IVA&period=max&api_key=YOUR_API_KEY